Abstract
Drug selectivity is arguably a critical concern for drug development. Recently, experimental evidence suggests that drugs have more selectivity than that afforded by differential affinity for different receptor subtypes. Drugs, acting at a single receptor, can selectively and differentially activate each of the multiple signaling pathways coupled to a receptor. This type of selectivity has been termed functional selectivity. Understanding functional selectivity and how to measure it will be important for new drug development.
Original language | English (US) |
---|---|
Pages (from-to) | e31-e36 |
Journal | Drug Discovery Today: Technologies |
Volume | 7 |
Issue number | 1 |
DOIs | |
State | Published - 2010 |
ASJC Scopus subject areas
- Biotechnology
- Molecular Medicine
- Drug Discovery